D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 59 Citations 11,108 124 World Ranking 1763 National Ranking 106
Medicine D-index 71 Citations 17,453 243 World Ranking 14472 National Ranking 668

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Inflammation

The scientist’s investigation covers issues in Cell biology, Immunology, Integrin, Signal transduction and Vascular permeability. His Cell biology research is multidisciplinary, relying on both Endothelium and Leukocyte Rolling. His work is connected to Inflammation, Platelet, Proinflammatory cytokine, Arthritis and Lipoxin, as a part of Immunology.

His studies in Platelet integrate themes in fields like Receptor and Cell adhesion molecule. His Integrin research is multidisciplinary, incorporating perspectives in Chemokine, Molecular biology and Cell adhesion. His work carried out in the field of Vascular permeability brings together such families of science as VE-cadherin, Neutrophil extravasation and Leukocyte extravasation.

His most cited work include:

  • Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial (489 citations)
  • Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation (458 citations)
  • Platelet-neutrophil-interactions: linking hemostasis and inflammation. (444 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Cell biology, Immunology, Acute kidney injury, Inflammation and Intensive care medicine. The Cell biology study combines topics in areas such as Integrin and Cell adhesion, Leukocyte Rolling. His research integrates issues of Molecular biology and Lung injury in his study of Immunology.

His Acute kidney injury research includes elements of Cardiac surgery, Renal replacement therapy, Kidney disease and Renal function. His study looks at the relationship between Inflammation and fields such as Immune system, as well as how they intersect with chemical problems. The various areas that Alexander Zarbock examines in his Intensive care medicine study include Perioperative, Complication, MEDLINE and Anesthesiology.

He most often published in these fields:

  • Cell biology (43.96%)
  • Immunology (37.46%)
  • Acute kidney injury (26.01%)

What were the highlights of his more recent work (between 2019-2021)?

  • Acute kidney injury (26.01%)
  • Intensive care medicine (17.34%)
  • Renal replacement therapy (11.15%)

In recent papers he was focusing on the following fields of study:

Alexander Zarbock focuses on Acute kidney injury, Intensive care medicine, Renal replacement therapy, Kidney disease and Internal medicine. His Acute kidney injury study incorporates themes from Clinical trial, Kidney, Perioperative, Cardiac surgery and Dialysis. His Intensive care medicine research is multidisciplinary, incorporating elements of Complication, Disease, MEDLINE and Urine output.

His Renal replacement therapy study combines topics in areas such as Adverse effect and Gynecology. Alexander Zarbock combines subjects such as Guideline, Absolute risk reduction and Intravascular volume status with his study of Kidney disease. His research investigates the link between Area under the curve and topics such as Chemokine that cross with problems in Integrin.

Between 2019 and 2021, his most popular works were:

  • COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. (61 citations)
  • Coronaviruses and SARS-CoV-2: A Brief Overview. (55 citations)
  • Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. (52 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Enzyme

Alexander Zarbock mostly deals with Acute kidney injury, Clinical trial, Renal replacement therapy, Intensive care medicine and Kidney disease. His Acute kidney injury study integrates concerns from other disciplines, such as Dialysis and Randomized controlled trial. His biological study spans a wide range of topics, including Anesthesia, Prospective cohort study, Biomarker and Cohort study.

Alexander Zarbock interconnects Guideline, Nephrology and Fluid management in the investigation of issues within Renal replacement therapy. His work deals with themes such as Disease, MEDLINE and Urine output, which intersect with Intensive care medicine. He has included themes like Renal function, Mace, Perioperative, Severity of illness and Intensive care unit in his Kidney disease study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial

Alexander Zarbock;John A. Kellum;Christoph Schmidt;Hugo Van Aken.
JAMA (2016)

683 Citations

Platelet-neutrophil-interactions: linking hemostasis and inflammation.

Alexander Zarbock;Alexander Zarbock;Renata K. Polanowska-Grabowska;Klaus Ley.
Blood Reviews (2007)

646 Citations

Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation

Alexander Zarbock;Kai Singbartl;Klaus Ley.
Journal of Clinical Investigation (2006)

585 Citations

Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial

Melanie Meersch;Christoph Schmidt;Andreas Hoffmeier;Hugo Van Aken.
Intensive Care Medicine (2017)

494 Citations

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

Tibor Kempf;Alexander Zarbock;Christian Widera;Stefan Butz.
Nature Medicine (2011)

462 Citations

Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup

Lakhmir S. Chawla;Rinaldo Bellomo;Azra Bihorac;Stuart L. Goldstein.
Nature Reviews Nephrology (2017)

457 Citations

Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow

Alexander Zarbock;Klaus Ley;Rodger P. McEver;Andrés Hidalgo.
Blood (2011)

439 Citations

Neutrophils scan for activated platelets to initiate inflammation

Vinatha Sreeramkumar;José M. Adrover;Ivan Ballesteros;Maria Isabel Cuartero.
Science (2014)

418 Citations

Spleen Tyrosine Kinase Syk Is Necessary for E-Selectin-Induced αLβ2 Integrin-Mediated Rolling on Intercellular Adhesion Molecule-1

Alexander Zarbock;Clifford A. Lowell;Klaus Ley.
Immunity (2007)

367 Citations

Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial.

Alexander Zarbock;Christoph Schmidt;Hugo Van Aken;Carola Wempe.
JAMA (2015)

353 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alexander Zarbock

John A. Kellum

John A. Kellum

University of Pittsburgh

Publications: 103

Oliver Soehnlein

Oliver Soehnlein

Karolinska Institute

Publications: 71

Claudio Ronco

Claudio Ronco

University of Padua

Publications: 57

Rinaldo Bellomo

Rinaldo Bellomo

University of Melbourne

Publications: 54

Dietmar Vestweber

Dietmar Vestweber

Max Planck Society

Publications: 51

Christian Weber

Christian Weber

Ludwig Maximilian University of Munich

Publications: 46

Andrés Hidalgo

Andrés Hidalgo

Spanish National Centre for Cardiovascular Research

Publications: 46

Markus Sperandio

Markus Sperandio

Ludwig-Maximilians-Universität München

Publications: 46

Klaus Ley

Klaus Ley

La Jolla Institute For Allergy & Immunology

Publications: 44

Can Ince

Can Ince

Erasmus University Rotterdam

Publications: 42

Rodger P. McEver

Rodger P. McEver

Oklahoma Medical Research Foundation

Publications: 36

Sean M. Bagshaw

Sean M. Bagshaw

University of Alberta

Publications: 34

Stuart L. Goldstein

Stuart L. Goldstein

Cincinnati Children's Hospital Medical Center

Publications: 32

Ravindra L. Mehta

Ravindra L. Mehta

University of California, San Diego

Publications: 25

Michael Darmon

Michael Darmon

Université Paris Cité

Publications: 24

Chirag R. Parikh

Chirag R. Parikh

Johns Hopkins University

Publications: 24

Trending Scientists

Vasek Hlavac

Vasek Hlavac

Czech Technical University in Prague

Michael D. Abràmoff

Michael D. Abràmoff

University of Iowa

Thomas Bonald

Thomas Bonald

Télécom ParisTech

Thong Ngee Goh

Thong Ngee Goh

National University of Singapore

Zhong-Yong Yuan

Zhong-Yong Yuan

Nankai University

Andrew W. Munro

Andrew W. Munro

University of Manchester

Schahram Akbarian

Schahram Akbarian

Icahn School of Medicine at Mount Sinai

Adam Zlotnick

Adam Zlotnick

Indiana University

Kristina B. Katsaros

Kristina B. Katsaros

University of Miami

Stuart W G Derbyshire

Stuart W G Derbyshire

National University of Singapore

Barbara Schneider

Barbara Schneider

Michigan State University

Philip S. Wells

Philip S. Wells

Ottawa Hospital

Mark E. Anderson

Mark E. Anderson

Johns Hopkins University School of Medicine

Patrick Maisonneuve

Patrick Maisonneuve

European Institute of Oncology

Geoffrey M. Evans

Geoffrey M. Evans

University of Newcastle Australia

Simon S. K. Lam

Simon S. K. Lam

University of Hong Kong

Something went wrong. Please try again later.